Education
About Us
Working with TipRanks
Follow Us
Vitrolife AB (SE:VITR)
:VITR
VITR Stock Chart & Stats
kr145.00
-kr3.40(-1.91%)
At close: 4:00 PM EST
kr145.00
-kr3.40(-1.91%)
Day’s Range― - ―
52-Week Rangekr126.30 - kr252.60
Previous CloseN/A
Volume81.91K
Average Volume (3M)92.36K
Market Cap
kr19.78B
Enterprise Valuekr20.03B
Total Cash (Recent Filing)kr921.00M
Total Debt (Recent Filing)kr1.99B
Price to Earnings (P/E)43.5
Beta0.77
Next Earnings
Feb 03, 2026EPS EstimateN/A
Last Dividend Ex-Date
Apr 30, 2025Dividend Yield0.77%
Share Statistics
EPS (TTM)0.75
Shares Outstanding135,447,190
10 Day Avg. Volume105,869
30 Day Avg. Volume92,365
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
Vitrolife AB News
VITR FAQ
What was Vitrolife AB’s price range in the past 12 months?
Vitrolife AB lowest stock price was kr126.30 and its highest was kr252.60 in the past 12 months.
What is Vitrolife AB’s market cap?
Vitrolife AB’s market cap is kr19.78B.
When is Vitrolife AB’s upcoming earnings report date?
Vitrolife AB’s upcoming earnings report date is Feb 03, 2026 which is in 103 days.
How were Vitrolife AB’s earnings last quarter?
Vitrolife AB released its earnings results on Oct 23, 2025. The company reported kr0.75 earnings per share for the quarter, missing the consensus estimate of kr0.937 by -kr0.187.
Is Vitrolife AB overvalued?
According to Wall Street analysts Vitrolife AB’s price is currently Overvalued.
Does Vitrolife AB pay dividends?
Vitrolife AB pays a Annually dividend of kr1.1 which represents an annual dividend yield of 0.77%. See more information on Vitrolife AB dividends here
What is Vitrolife AB’s EPS estimate?
Vitrolife AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vitrolife AB have?
Vitrolife AB has 135,447,190 shares outstanding.
What happened to Vitrolife AB’s price movement after its last earnings report?
Vitrolife AB reported an EPS of kr0.75 in its last earnings report, missing expectations of kr0.937. Following the earnings report the stock price went down -6.147%.
Which hedge fund is a major shareholder of Vitrolife AB?
Currently, no hedge funds are holding shares in SE:VITR
Company Description
Vitrolife AB
Vitrolife AB (publ), a medical device company, develops, produces, and markets products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products. The company also offers EmbryoScope and Primo Vision time-lapse systems; time-lapse dishes; evaluation tools for time-lapse systems; and Octax laser and imaging systems, as well as log and guard systems and wireless sensors. It operates in Europe, the Middle East, and Africa; Asia; Japan and Pacific; and North and South America. The company was formerly known as Scandinavian IVF Science and changed its name to Vitrolife AB (publ) in 1998. Vitrolife AB (publ) was founded in 1994 and is headquartered in Gothenburg, Sweden.
Technical Analysis
Getinge
―
BICO Group AB Class B
―
CellaVision AB
―
Xvivo Perfusion AB
―
Sectra AB Class B
―
Options Prices
Currently, No data available
---